Statements (56)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:disease
|
| gptkbp:affectsOrgan |
liver
|
| gptkbp:cause |
liver cancer
cirrhosis chronic hepatitis |
| gptkbp:causedBy |
gptkb:Hepatitis_B_virus
|
| gptkbp:complication |
gptkb:hepatic_encephalopathy
liver failure hepatocellular carcinoma portal hypertension ascites |
| gptkbp:diagnosedBy |
blood test
|
| gptkbp:firstDescribed |
1965
|
| gptkbp:hasGlobalPrevalence |
over 250 million chronic cases
|
| gptkbp:hasVaccineEfficacy |
over 95%
|
| gptkbp:hasVaccineSchedule |
birth, 1 month, 6 months
|
| gptkbp:hasVaccineType |
plasma-derived vaccine
recombinant vaccine |
| https://www.w3.org/2000/01/rdf-schema#label |
Hepatitis B
|
| gptkbp:ICD-10_code |
gptkb:B18.0
B16 B18.1 |
| gptkbp:isNotifiableDisease |
true
|
| gptkbp:MeSH_ID |
D006509
|
| gptkbp:mortalityRate |
about 820,000 deaths per year (2022)
|
| gptkbp:OMIM |
610424
|
| gptkbp:prevention |
gptkb:Hepatitis_B_vaccine
vaccine safe injection practices screening blood products safe sex |
| gptkbp:riskFactor |
mother-to-child transmission
sharing needles blood transfusion unprotected sex |
| gptkbp:symptom |
nausea
vomiting abdominal pain fatigue jaundice loss of appetite dark urine asymptomatic in some cases |
| gptkbp:transmission |
blood
sexual contact perinatal |
| gptkbp:treatment |
gptkb:insulin
gptkb:lamivudine gptkb:adefovir gptkb:entecavir antiviral drug tenofovir pegylated interferon |
| gptkbp:bfsParent |
gptkb:disease
gptkb:Vaccination |
| gptkbp:bfsLayer |
4
|